{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:14:23Z","timestamp":1792131263469,"version":"4.4.0"},"reference-count":147,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Romanian Ministry of Research and Innovation","award":["(PFE)-14\/2022-2024"],"award-info":[{"award-number":["(PFE)-14\/2022-2024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Helicobacter pylori is the first formally recognized bacterial carcinogen and the most important single digestive pathogen responsible for the induction of gastroduodenal diseases such as gastritis, peptic ulcer, and, finally, gastric neoplasia. The recently reported high rates of antimicrobial drug resistance hamper the current therapies of H. pylori, with therapeutic failure reaching up to 40% of patients. In this context, new treatment options and strategies are urgently needed, but the successful development of these new therapeutic tools is conditioned by the understanding of the high adaptability of H. pylori to the gastric acidic environment and the complex pathogenic mechanism. Due to several advantages, including good antibacterial efficiency, possible targeted delivery, and long tissular persistence, silver nanoparticles (AgNPs) offer the opportunity of exploring new strategies to improve the H. pylori therapy. A new paradigm in the therapy of H. pylori gastric infections using AgNPs has the potential to overcome the current medical limitations imposed by the H. pylori drug resistance, which is reported for most of the current organic antibiotics employed in the classical therapies. This manuscript provides an extensive overview of the pathology of H. pylori-induced gastritis, gastric cancer, and extradigestive diseases and highlights the possible benefits and limitations of employing AgNPs in the therapeutic strategies against H. pylori infections.<\/jats:p>","DOI":"10.3390\/pharmaceutics14071463","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T01:57:11Z","timestamp":1657850231000},"page":"1463","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Helicobacter Pylori-Induced Gastric Infections: From Pathogenesis to Novel Therapeutic Approaches Using Silver Nanoparticles"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-1823","authenticated-orcid":false,"given":"Romelia","family":"Pop","sequence":"first","affiliation":[{"name":"Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-0451","authenticated-orcid":false,"given":"Alexandru-Flaviu","family":"T\u0103b\u0103ran","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-3719","authenticated-orcid":false,"given":"Andrei Paul","family":"Ungur","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrada","family":"Negoescu","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornel","family":"C\u0103toi","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ierardi, E., Losurdo, G., Mileti, A., Paolillo, R., Giorgio, F., Principi, M., and Di Leo, A. (2020). The puzzle of coccoid forms of Helicobacter pylori: Beyond basic science. Antibiotics, 9.","DOI":"10.3390\/antibiotics9060293"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17600","DOI":"10.1073\/pnas.1418230111","article-title":"In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation","volume":"111","author":"Thamphiwatana","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bpg.2006.11.001","article-title":"Treatment of Helicobacter pylori","volume":"21","author":"Wolle","year":"2007","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa\u2013associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bpg.2006.10.003","article-title":"Helicobacter pylori and extragastric diseases","volume":"21","author":"Franceschi","year":"2007","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jocn.2013.11.018","article-title":"Association between Helicobacter pylori infection and dementia","volume":"21","author":"Huang","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e12398","DOI":"10.1111\/hel.12398","article-title":"Meta-analysis: Association of Helicobacter pylori infection with Parkinson\u2019s diseases","volume":"22","author":"Shen","year":"2017","journal-title":"Helicobacter"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4291\/wjgp.v5.i4.400","article-title":"Helicobacter pylori and neurological diseases: Married by the laws of inflammation","volume":"5","year":"2014","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/BF02072207","article-title":"Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis","volume":"150","author":"Blecker","year":"1991","journal-title":"Eur. J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.71.5.437","article-title":"Relation of Helicobacter pylori infection and coronary heart disease","volume":"71","author":"Mendall","year":"1994","journal-title":"Heart"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3803\/EnM.2018.33.1.33","article-title":"Association of adipokines with development and progression of nonalcoholic fatty liver disease","volume":"33","author":"Boutari","year":"2018","journal-title":"Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bpg.2006.10.002","article-title":"Helicobacter pylori and benign upper digestive disease","volume":"21","author":"Lai","year":"2007","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bpg.2007.01.001","article-title":"The inflammatory and immune response to Helicobacter pylori infection","volume":"21","author":"Robinson","year":"2007","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1523-5378.2011.00829.x","article-title":"Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?","volume":"16","author":"Hsu","year":"2011","journal-title":"Helicobacter"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000444362","article-title":"Helicobacter pylori treatment failure: The rationale for alternative antibiotics","volume":"93","author":"Smith","year":"2016","journal-title":"Digestion"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0255-0857.142256","article-title":"Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat","volume":"32","author":"Pandya","year":"2014","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.3748\/wjg.v20.i40.14973","article-title":"Standard triple therapy for Helicobacter pylori infection in China: A meta-analysis","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1523-5378.2011.00856.x","article-title":"Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children","volume":"16","author":"Liu","year":"2011","journal-title":"Helicobacter"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrgastro.2017.57","article-title":"Helicobacter pylori infection and antibiotic resistance: A WHO high priority?","volume":"14","author":"Dang","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/314079","article-title":"Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients","volume":"31","author":"Kollef","year":"2000","journal-title":"Clin. Infect.Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.addr.2005.04.005","article-title":"Clinical impact and relevance of antibiotic resistance","volume":"57","author":"French","year":"2005","journal-title":"Adv. Drug Deliv.Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(10)70003-0","article-title":"The continuing crisis in antibiotic resistance","volume":"36","author":"French","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: A systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","article-title":"Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community","volume":"70","author":"Megraud","year":"2021","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Navarro-Rodriguez, T., Silva, F.M., Barbuti, R.C., Mattar, R., Moraes-Filho, J.P., de Oliveira, M.N., Bogsan, C.S., Chinzon, D., and Eisig, J.N. (2013). Association of a Probiotic to a Helicobacter pylori Eradication Regimen Does Not Increase efficacy or decreases the adverse effects of the treatment: A prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-56"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15537\/smj.2015.3.10124","article-title":"The effects of probiotics on treatment of Helicobacter pylori eradication in children","volume":"36","author":"Akcam","year":"2013","journal-title":"Saudi Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fcimb.2017.00168","article-title":"Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance","volume":"7","author":"Hu","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e12565","DOI":"10.1111\/hel.12565","article-title":"Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis","volume":"24","author":"Ko","year":"2019","journal-title":"Helicobacter"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4292\/wjgpt.v6.i4.183","article-title":"Antibiotic treatment for Helicobacter pylori: Is the end coming?","volume":"6","author":"Kim","year":"2015","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/14756360903179518","article-title":"Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc (II)\u2013famotidine complex","volume":"25","author":"Amin","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1083-4389.2004.00264.x","article-title":"Selective and effective bactericidal activity of the cobalt (II) cation against Helicobacter pylori","volume":"9","author":"Bruggraber","year":"2004","journal-title":"Helicobacter"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.2147\/IJN.S134526","article-title":"Antibacterial properties and toxicity from metallic nanomaterials","volume":"12","author":"Vimbela","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.arabjc.2016.02.005","article-title":"Anti-Helicobacter pylori, cytotoxicity and catalytic activity of biosynthesized gold nanoparticles: Multifaceted application","volume":"12","author":"Gopinath","year":"2019","journal-title":"Arab. J. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00253-009-2159-5","article-title":"Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli","volume":"85","author":"Li","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1021\/acsnano.9b08108","article-title":"Click reaction for reversible encapsulation of single yeast cells","volume":"13","author":"Geng","year":"2019","journal-title":"ACS Nano"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1039\/C7NR08556G","article-title":"Single cells in nanoshells for the functionalization of living cells","volume":"10","author":"Geng","year":"2018","journal-title":"Nanoscale"},{"key":"ref_39","first-page":"1236","article-title":"Silver nanoparticle in biosensor and bioimaging: Clinical perspectives","volume":"68","author":"Tan","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/smll.201201779","article-title":"Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers","volume":"9","author":"Bao","year":"2013","journal-title":"Small"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7150\/thno.8934","article-title":"Enhanced plasmonic resonance energy transfer in mesoporous silica-encased gold nanorod for two-photon-activated photodynamic therapy","volume":"4","author":"Chen","year":"2014","journal-title":"Theranostics"},{"key":"ref_42","unstructured":"(2022, June 27). Available online: https:\/\/prisma-statement.org."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2036.1995.tb00780.x","article-title":"The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease","volume":"9","author":"Blaser","year":"1995","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.69.3.1625-1629.2001","article-title":"Implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion","volume":"69","author":"Audibert","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1128\/IAI.71.11.6573-6581.2003","article-title":"Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease","volume":"71","author":"Nilsson","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1046\/j.1365-2958.1997.3101672.x","article-title":"Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution","volume":"23","author":"Hacker","year":"1997","journal-title":"Mol. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3109\/00365529309103125","article-title":"Effect of Helicobacter pylori eradication on antral gastrin-and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations","volume":"28","author":"Queiroz","year":"1993","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bj.2015.06.002","article-title":"Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis","volume":"39","author":"Kao","year":"2016","journal-title":"Biomed. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/155.11.1054","article-title":"Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease","volume":"155","author":"Nomura","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2958.1996.tb02612.x","article-title":"The vacuolating cytotoxin of Helicobacter pylori","volume":"20","author":"Cover","year":"1996","journal-title":"Mol. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3904\/kjim.2001.16.1.8","article-title":"Relevance of vacA genotypes of Helicobacter pylori to cagA status and its clinical outcome","volume":"16","author":"Park","year":"2001","journal-title":"Korean J. Intern. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1572-0241.2001.03685.x","article-title":"Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease","volume":"96","author":"Miehlke","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_54","first-page":"531","article-title":"Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome","volume":"110","author":"Peek","year":"1998","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.micro.54.1.615","article-title":"The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer","volume":"54","author":"Ernst","year":"2000","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.93.25.14648","article-title":"cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors","volume":"93","author":"Censini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00001574-200001000-00005","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"16","author":"McGee","year":"2000","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1469-0691.2005.01207.x","article-title":"Pathogenicity of Helicobacter pylori infection","volume":"11","author":"Bek","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-018-0466-9","article-title":"The impacts of H. pylori virulence factors on the development of gastroduodenal diseases","volume":"25","author":"Chang","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"426309","DOI":"10.1155\/2014\/426309","article-title":"H. pylori virulence factors: Influence on immune system and pathology","volume":"2014","author":"Kalali","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1440-1746.2011.06961.x","article-title":"Future candidates for indications of Helicobacter pylori eradication: Do the indications need to be revised?","volume":"27","author":"Lee","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s10620-011-1703-1","article-title":"Endoscopic gastritis: What does it mean?","volume":"56","author":"Lee","year":"2011","journal-title":"Dig. Dis.Sci."},{"key":"ref_63","unstructured":"Leib, M. (2021, May 31). Therapy of GI Diseases: What\u2019s New with Antiemetics, Antacids, and Probiotics. Available online: http:\/\/www.dvm360storage.com\/cvc\/proceedings\/dc\/Gastrointestinal%20Medicine\/Leib\/Leib,%20Michael_Therapy_GI_diseases_STYLED.pdf."},{"key":"ref_64","unstructured":"Guilford, W.G., Center, S.A., Strombeck, D.R., Williams, D.A., and Meyer, D.J. (1990). Strombeck\u2019s Small Animal Gastroenterology, WB Saunders Co."},{"key":"ref_65","unstructured":"Westblom, T.U., Czinn, S.J., and Nedrud, J.G. (2012). Gastroduodenal Disease and Helicobacter pylori: Pathophysiology, Diagnosis and Treatment, Springer Science & Business Media."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/111.2.241","article-title":"Molecular alterations in early gastric carcinomas: No apparent correlation with Helicobacter pylori status","volume":"111","author":"Blok","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365529109104000","article-title":"Chronic gastritis: Progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects","volume":"26","author":"Villako","year":"1991","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1026638014062","article-title":"Redox regulation of interleukin-8 expression in MKN28 cells","volume":"44","author":"Shimada","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdi277","article-title":"Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t (11; 18): A 10-year updated follow-up of a prospective study","volume":"16","author":"Montalban","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.revmed.2004.02.002","article-title":"Les lymphomes gastriques du MALT","volume":"25","year":"2004","journal-title":"Rev. M\u00e9decine Interne"},{"key":"ref_71","first-page":"285","article-title":"Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type","volume":"142","author":"Hussell","year":"1993","journal-title":"Am. J. Pathol."},{"key":"ref_72","first-page":"61","article-title":"Gastric MALT lymphoma and Helicobacter pylori","volume":"69","author":"Wotherspoon","year":"1996","journal-title":"Yale J. Biol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10096-014-2207-7","article-title":"Helicobacter pylori infection and the risk of acute coronary syndrome: A nationwide retrospective cohort study","volume":"34","author":"Lai","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/hel.12188","article-title":"Helicobacter pylori infection increase the risk of myocardial infarction: A meta-analysis of 26 studies involving more than 20,000 participants","volume":"20","author":"Liu","year":"2015","journal-title":"Helicobacter"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.3748\/wjg.v12.i48.7815","article-title":"H. pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease","volume":"12","author":"Lenzi","year":"2006","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.atherosclerosis.2004.08.025","article-title":"Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT)","volume":"178","author":"Sawayama","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2362.2005.01471.x","article-title":"Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan","volume":"35","author":"Inaba","year":"2005","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1083-4389.2004.00261.x","article-title":"Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Ando","year":"2004","journal-title":"Helicobacter"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1532\/IJH97.04146","article-title":"Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan","volume":"81","author":"Fujimura","year":"2005","journal-title":"Int. J. Hematol."},{"key":"ref_80","first-page":"A67","article-title":"The effect of bile on protein expression by intestinal Helicobacters, determined using ProteinChip (r) Technology","volume":"49","author":"Hynes","year":"2001","journal-title":"Gut"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.2002.01282.x","article-title":"Helicobacter species and hepatobiliary diseases","volume":"16","author":"Leong","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"13996","DOI":"10.1016\/S0021-9258(18)92801-2","article-title":"Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones","volume":"266","author":"Harvey","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2741\/Swidsinski","article-title":"The role of bacteria in gallstone pathogenesis","volume":"6","author":"Swidsinski","year":"2001","journal-title":"Front. Biosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1091-255X(00)80100-6","article-title":"Pigment gallstone pathogenesis: Slime production by biliary bacteria is more important than beta-glucuronidase production","volume":"4","author":"Stewart","year":"2000","journal-title":"J. Gastrointest. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/labinvest.2010.109","article-title":"Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-\u03b2 1-induced inflammatory signaling","volume":"90","author":"Ki","year":"2010","journal-title":"Lab. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1523-5378.2011.00883.x","article-title":"Extragastric manifestations of Helicobacter pylori infection","volume":"16","author":"Suzuki","year":"2011","journal-title":"Helicobacter"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1590-8658(03)00060-4","article-title":"Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls","volume":"35","author":"Chen","year":"2003","journal-title":"Dig. Liver Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1523-5378.2003.00167.x","article-title":"Helicobacter pylori and extragastric diseases\u2013other Helicobacters","volume":"8","author":"Gasbarrini","year":"2003","journal-title":"Helicobacter"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"dela Pena-Ponce, M.G., Jimenez, M.T., Hansen, L.M., Solnick, J.V., and Miller, L.A. (2017). The Helicobacter pylori type IV secretion system promotes IL-8 synthesis in a model of pediatric airway epithelium via p38 MAP kinase. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183324"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s10096-017-2972-1","article-title":"Helicobacter pylori infection increases the risk of adult-onset asthma: A nationwide cohort study","volume":"36","author":"Wang","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fneur.2017.00526","article-title":"Clinical implications of associations between headache and gastrointestinal disorders: A study using the hallym smart clinical data warehouse","volume":"8","author":"Lee","year":"2017","journal-title":"Front. Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v24.i12.1343","article-title":"Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis","volume":"24","author":"Yang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s11596-017-1813-x","article-title":"Long-term Helicobacter pylori infection does not induce tauopathy and memory impairment in SD rats","volume":"37","author":"Zhou","year":"2017","journal-title":"Curr. Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10522-017-9676-x","article-title":"Helicobacter pylori-induced premature senescence of extragastric cells may contribute to chronic skin diseases","volume":"18","author":"Lewinska","year":"2017","journal-title":"Biogerontology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/idoj.IDOJ_77_17","article-title":"Relationship between disease activity and Helicobacter pylori infection in patients with vitiligo","volume":"9","author":"Bakry","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e12520","DOI":"10.1111\/hel.12520","article-title":"Helicobacter pylori and extragastric diseases","volume":"23","author":"Giupponi","year":"2018","journal-title":"Helicobacter"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2217\/nnm-2019-0329","article-title":"Eradication of Helicobacter pylori: The power of nanosized formulations","volume":"15","author":"Zhang","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.molpharmaceut.9b01264","article-title":"New silver (I) coordination compound loaded into polymeric nanoparticles as a strategy to improve in vitro anti-Helicobacter pylori activity","volume":"17","author":"Silva","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_99","unstructured":"Mansouri, F., Saffari, M., Moniri, R., Sedaghat, H., Moosavi, G.A., Molaghanbari, M., and Razavizade, M. (2022, June 27). Investigation of the Effect of Silver Nanoparticles alone and Their Combination with Clarithromycin on H. pylori Isolates. Available online: https:\/\/assets.researchsquare.com\/files\/rs-1631922\/v1\/6ec0820c-530c-443f-adb4-097c17d48bf8.pdf?c=1653660296."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1175325","article-title":"Looming global-scale failures and missing institutions","volume":"325","author":"Walker","year":"2009","journal-title":"Science"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/591698","article-title":"The impact of antimicrobial-resistant, health care\u2013associated infections on mortality in the United States","volume":"47","author":"Klevens","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10388","article-title":"Antibiotic resistance is ancient","volume":"477","author":"King","year":"2011","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: Is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1038\/s41467-021-23659-y","article-title":"Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1039\/C9SC02032B","article-title":"Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli","volume":"10","author":"Wang","year":"2019","journal-title":"Chem. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Nyabadza, A., V\u00e1zquez, M., Coyle, S., Fitzpatrick, B., and Brabazon, D. (2021). Review of materials and fabrication methods for flexible nano and micro-scale physical and chemical property sensors. Appl. Sci., 11.","DOI":"10.20944\/preprints202108.0351.v1"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fmicb.2014.00551","article-title":"A new strategy to fight antimicrobial resistance: The revival of old antibiotics","volume":"5","author":"Cassir","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2672.2012.05253.x","article-title":"Silver nanoparticles: The powerful nanoweapon against multidrug-resistant bacteria","volume":"112","author":"Rai","year":"2012","journal-title":"J. Appl. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1166\/jnn.2007.785","article-title":"Synthesis, characterization and catalytic application of silver nanoshell coated functionalized polystyrene beads","volume":"7","author":"Jana","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"126608","DOI":"10.1016\/j.matlet.2019.126608","article-title":"Green synthesis of gold nanoparticles: Preparation, characterization, cytotoxicity, and anti-bacterial activities","volume":"256","author":"Awad","year":"2019","journal-title":"Mater. Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.joen.2013.08.022","article-title":"Evaluation of the antibacterial efficacy of silver nanoparticles against Enterococcus faecalis biofilm","volume":"40","author":"Wu","year":"2014","journal-title":"J. Endod."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1021\/es703238h","article-title":"Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria","volume":"42","author":"Choi","year":"2008","journal-title":"Environ. Sci. Technol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.3390\/molecules20058856","article-title":"Silver nanoparticles as potential antibacterial agents","volume":"20","author":"Franci","year":"2015","journal-title":"Molecules"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2147\/IJN.S121956","article-title":"The antimicrobial activity of nanoparticles: Present situation and prospects for the future","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"ref_115","first-page":"506","article-title":"Influence of silver-hydroxyapatite nanocomposite coating on biofilm formation of joint prosthesis and its mechanism","volume":"64","author":"Zhao","year":"2015","journal-title":"West Indian Med. J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/nn300934k","article-title":"Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles","volume":"6","author":"Li","year":"2012","journal-title":"ACS Nano"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/IJN.S241183","article-title":"Silver nanoparticles for the therapy of tuberculosis","volume":"15","author":"Matea","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"015001","DOI":"10.1088\/1748-6041\/10\/1\/015001","article-title":"Synthesis, characterization, antimicrobial activity and mechanism of a novel hydroxyapatite whisker\/nano zinc oxide biomaterial","volume":"10","author":"Yu","year":"2014","journal-title":"Biomed. Mater."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.2147\/IJN.S61143","article-title":"Synthesis, characterization, and antimicrobial activity of an ampicillin-conjugated magnetic nanoantibiotic for medical applications","volume":"9","author":"Hussein","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/ja309812z","article-title":"Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency","volume":"135","author":"Lesniak","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Sarwar, A., Katas, H., Samsudin, S.N., and Zin, N.M. (2015). Regioselective sequential modification of chitosan via azide-alkyne click reaction: Synthesis, characterization, and antimicrobial activity of chitosan derivatives and nanoparticles. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123084"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00253-011-3213-7","article-title":"Photocatalytic disinfection using titanium dioxide: Spectrum and mechanism of antimicrobial activity","volume":"90","author":"Foster","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"15824","DOI":"10.1038\/srep15824","article-title":"Alteration of intracellular protein expressions as a key mechanism of the deterioration of bacterial denitrification caused by copper oxide nanoparticles","volume":"5","author":"Su","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3389\/fmicb.2020.01705","article-title":"Antimicrobial and antibiofilm activities of new synthesized Silver Ultra-NanoClusters (SUNCs) against Helicobacter pylori","volume":"11","author":"Grande","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s11671-015-0747-0","article-title":"Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells","volume":"10","author":"Gurunathan","year":"2015","journal-title":"Nanoscale Res. Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.3390\/ijms13089923","article-title":"Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: Characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori","volume":"13","author":"Amin","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1038\/s41598-019-42112-1","article-title":"Unveiling the potentials of biocompatible silver nanoparticles on human lung carcinoma A549 cells and Helicobacter pylori","volume":"9","author":"Saravanakumar","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_128","first-page":"1102","article-title":"In Vitro Study Of Antimicrobial Activity Of Silver Nanoparticles Usage (Curcuma Longa L.) Rhizomes Against Helicobacter pylori","volume":"19","author":"Mohammed","year":"2019","journal-title":"Plant Arch."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s42452-019-0362-2","article-title":"Phytogenic synthesis of silver nanobactericides for anti-biofilm activity against human pathogen H. pylori","volume":"1","author":"Prasad","year":"2019","journal-title":"SN Appl. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10876-020-01813-8","article-title":"Synthesis and Characterization of Pyrogallol Capped Silver Nanoparticles and Evaluation of Their In Vitro Anti-Bacterial, Anti-cancer Profile against AGS Cells","volume":"32","author":"Sampath","year":"2020","journal-title":"J. Clust. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"135824","DOI":"10.1155\/2014\/135824","article-title":"Green synthesis of silver nanoparticles: Structural features and in vivo and in vitro therapeutic effects against Helicobacter pylori induced gastritis","volume":"2014","author":"Amin","year":"2014","journal-title":"Bioinorg. Chem. Appl."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.arabjc.2015.11.011","article-title":"Biogenic synthesis, characterization of antibacterial silver nanoparticles and its cell cytotoxicity","volume":"10","author":"Gopinath","year":"2017","journal-title":"Arab. J. Chem."},{"key":"ref_133","first-page":"207","article-title":"Influence of N-acylhomoserine lac-tonase silver nanoparticles on the quorum sensing system of Helicobacter pylori: A potential strategy to combat biofilm formation","volume":"60","author":"Gopalakrishnan","year":"2020","journal-title":"J. BasicMicrobiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"891144","DOI":"10.3389\/fmicb.2022.891144","article-title":"Viola betonicifolia-Mediated Biosynthesis of Silver Nanoparticles for Improved Biomedical Applications","volume":"13","author":"Jang","year":"2022","journal-title":"Front.Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Gomez, C., Hallot, G., Laurent, S., and Port, M. (2021). Medical Applications of Metallic Bismuth Nanoparticles. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111793"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"461034","DOI":"10.1155\/2014\/461034","article-title":"Does Long-Term Use of Silver Nanoparticles Have Persistent Inhibitory Effect on H. pylori Based on Mongolian Gerbil\u2019s Model?","volume":"2014","author":"Kuo","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/bab.1341","article-title":"Innovative approach for urease inhibition by Ficus carica extract\u2013fabricated silver nanoparticles: An in vitro study","volume":"62","author":"Borase","year":"2015","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_138","first-page":"1197","article-title":"Evaluation of potent silver nanoparticles production from Agaricus bisporus against Helicobacter pylori","volume":"57","author":"Radif","year":"2020","journal-title":"Pak. J. Agri. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Sampath, G., Govarthanan, M., Sridharan, K., Prabhusaran, N., Rameshkumar, N., Krishnan, M., and Nagarajan, K. (2022). Isolation and identification of metronidazole resistance Helicobacter pylori from gastric patients in the southeastern region of India and its advanced antibacterial treatment using biological silver oxide nanoparticles. Biochem. Eng. J., 108445.","DOI":"10.1016\/j.bej.2022.108445"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2014.06.020","article-title":"Eradication of Helicobacter pylori: Past, present and future","volume":"189","author":"Lopes","year":"2014","journal-title":"J. Control Release"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1097\/MJT.0000000000000389","article-title":"Role of bismuth in the eradication of Helicobacter pylori","volume":"24","author":"Alkim","year":"2017","journal-title":"Am. J.Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"12037","DOI":"10.1039\/D0CS00031K","article-title":"Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles","volume":"50","author":"Griffith","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1039\/b601764a","article-title":"Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate","volume":"21","author":"Chen","year":"2006","journal-title":"Chem.Commun."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Chakraborti, S., Bhattacharya, S., Chowdhury, R., and Chakrabarti, P. (2013). The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070776"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jmmm.2019.04.076","article-title":"Synergistic effects of nanoparticle heating and amoxicillin on H. pylori inhibition","volume":"485","author":"Wu","year":"2019","journal-title":"J. Magn. Magn. Mater."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10611860310001647771","article-title":"Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori","volume":"11","author":"Umamaheshwari","year":"2003","journal-title":"J. Drug Target."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.actbio.2010.08.028","article-title":"Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori","volume":"7","author":"Chang","year":"2011","journal-title":"Acta Biomater."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/7\/1463\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:50:10Z","timestamp":1760140210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/7\/1463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":147,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["pharmaceutics14071463"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14071463","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}